Subash Arumugam

• Responsible for any POC, Play book, Roadmap & delivery plan for scaling
• Responsible to maintain Heatmap - Up-To-Date for all applications , Roadmap for Scaled delivery plan in key applications, Req Automation through Catalogues, Automating Testing.
• Collaborate with DevOps lead for the resource availability
• Identify & arrive at Cost estimation for the scaled projects
• Primarily a POD lead running scrum for more than one projects
• Implementing Agile Model for Scaled Delivery
• Coach team members on the agile process and ensure the team members understand their role and ownership
• Daily scrum or standup meetings to follow up on the ongoing tasks and risks
• Managing the demand backlogs, prioritizing the pipeline with product owner / delivery lead
• Scaled Delivery as well as current running demands/projects in PT&D
• Collaborate with Capability/Site IT to identify & share actual Business Impact of unplanned outages with SSD leadership team
• Ensure the RCA for the high priority incidents are delivered on time
• PRB closure with 100% Full mitigation in place and P1/P2 - PRB 100% tagging
• Supported BAU as and when required

• Responsibility to BAU delivery in operations IT QC & PTD for Lab Informatics applications.
• Lead the L2 and L3 support for the following applications

BIOVIA ELN- Electronic Lab Notebook

Agilent OpenLAB ECM

BIOVIA LES

• Responsible to initiate and implement standard and Normal changes whenever needed.
• Deployed the below Projects

OpenLAB CDS and ECM Upgrade to v3.6 (Q4 2018 – Q2 2020)

BIOVIA ONELAB for QC Operations (Since Q4 2019)

BIOVIA ONELAB for Development

• Collaborated with teams to define, strategize and implement refresh and EOSL activities.
• Analyzed problematic areas to provide recommendations and solutions.
• Created and developed detailed work plans to meet business priorities and deadlines.

• Transition lead for ELN suite of applications in R&D early science and Medimmune portfolio.
• Build & Stabilized the ELN Team. Acted as the key person to integrate the ELN support across R&D with one cross functional team.
• Lead the BAU delivery for MedChem, BioELN and Medimmune ELN.
• Initiating and implementing standard and Normal changes whenever needed.
• Worked on Incident, Change and Problem management of the information systems.
• Lead a team of 5 members in supporting the Lab Informatics Tools.
• Deployed the PerkinElmer ELN v17 (Q4 2016 to Q3 2017)upgrade project from version 13.
• Broke down and evaluated user problems, using test scripts, personal expertise and probing questions.
• Collaborated with vendors to resolve advanced problems.

• IT system owner for ELN suite of applications
• Responsible for support and project delivery PerkinElmer and IDBS ELN system
• Got certified training for SDMS Nugenesis 8 and provided BAU support for the same.
• Responsible for transition of Lab applications from Amgen to Cognizant.
• Responsible for application packaging and re-packaging whenever needed.
• Working on Incident, Change and Problem management of the information systems
• Provided weekly status reports for the Business management team.

• Provided the production support for a set of assigned applications supported by HCL in Pharmaceutical Science of Pfizer.
• L2 and L3 ticket handling within Service Level Agreements and ensure the identified application enhancement deliverables.
• Ensuring all the applications up and running normal for Pfizer business to use. For any issues, the relevant stakeholders to be approached for the remedy in order for bringing the applications back to normal
• Initiating and implementing the Pfizer RFC (Request for change) process and deployed the tested source in the production servers
• Coordinate with Business during the User Acceptance (Validation and Verification) and make sure all the defects are closed on time to meet the overall milestone and schedule.
• Gather new requirements for different modules, working with vendor for releases of the enhancements for the application requested by the users and planning work for subsequent releases.